Works by Garrison, Mitchell

Results: 3
    1
    2

    Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib.

    Published in:
    2019
    By:
    • Symonds, Lynn;
    • Linden, Hannah;
    • Gadi, Vijayakrishna;
    • Korde, Larissa;
    • Rodler, Eve;
    • Gralow, Julie;
    • Redman, Mary;
    • Baker, Kelsey;
    • Wu, Quan Vicky;
    • Jenkins, Isaac;
    • Kurland, Brenda;
    • Garrison, Mitchell;
    • Smith, Julie;
    • Anderson, Jeanne;
    • Van Haelst, Carol;
    • Seattle Cancer Care Alliance Network Investigators;
    • Specht, Jennifer
    Publication type:
    journal article
    3

    Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 8, p. 1523, doi. 10.3109/10428194.2010.491137
    By:
    • Gopal, Ajay K.;
    • Press, Oliver W.;
    • Shustov, Andrei R.;
    • Petersdorf, Stephen H.;
    • Gooley, Ted A.;
    • Daniels, Jasmine T.;
    • Garrison, Mitchell A.;
    • Gjerset, George F.;
    • Lonergan, Matthew;
    • Murphy, Anne E.;
    • Smith, Julie C.;
    • Pagel, John M.
    Publication type:
    Article